Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Brain Neoplasms 3Recurrence 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Squamous Cell Carcinoma of Head and Neck 1Skin Squamous Cell Cancer 1Rare Tumor 1Penile Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1NSCLC 1Lung Neoplasms 1Carcinoma 1Advanced Gastric Cancer 1

Interventions

Cisplatin 39Radiotherapy 21Carboplatin 21Cetuximab 20Paclitaxel 19Docetaxel 17Radiotherapy, Intensity-Modulated 15pembrolizumab 14Fluorouracil 13Drug Therapy 10Nivolumab 8Radiation 6cemiplimab 5atezolizumab 5Panitumumab 5Oxaliplatin 5Erlotinib Hydrochloride 5Chemoradiotherapy 5Afatinib 5Surgical Procedures, Operative 4durvalumab 3Surveys and Questionnaires 3Methotrexate 3Leucovorin 3Lapatinib 3130-nm albumin-bound paclitaxel 3toripalimab 2palbociclib 2osimertinib 2dacomitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Squamous Cell × dacomitinib × Clear all
NCT01728233 2021-05-14

HER-Uro01

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
32 enrolled
Genitourinary

Carcinoma, Squamous Cell, Penile Neoplasms

NCT01449201 2014-09-30

PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma

Yonsei University

Phase 2 Completed
49 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡